Woon, D. T. S., Finelli, A., Cheung, D. C., Martin, L. J., Alibhai, S., Wallis, C. J. D., Diong, C., Saskin, R., Kulkarni, G., & Fleshner, N. (2021). A population-based study comparing outcomes for patients with metastatic castrate resistant prostate cancer treated by urologists or medical oncologists with first line abiraterone acetate or enzalutamide. Urology.

Woon, D. T. S., Finelli, A., Cheung, D. C., Martin, L. J., Alibhai, S., Wallis, C. J. D., Diong, C., Saskin, R., Kulkarni, G., & Fleshner, N. (2021). A population-based study comparing outcomes for patients with metastatic castrate resistant prostate cancer treated by urologists or medical oncologists with first line abiraterone acetate or enzalutamide. Urology. https://doi.org/10.1016/j.urology.2020.11.080